H1 Blog

MAY 4, 2023

Insights for Thought Leading Stakeholder Engagement to Decrease Medication Non-Adherence Pharmaceutical companies have long recognized the importance of engaging key opinion leaders (KOLs) to gain insight and support for clinical research, drug development, and medical education.

Pharmaceutical Companies 52

Pharmaceutical Companies Clinical Research Pharma Companies Pharmaceuticals 52

H1 Blog

JULY 30, 2024

The recent draft by the FDA introduces additional guidelines for Diversity Action Plans aimed at improving diversity in clinical research. Quality insights make a difference and H1 has the data needed to support compliance with FDA requirements and diverse clinical trials. Find out more by requesting a demo today.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

Vial

JUNE 24, 2024

The fields of artificial intelligence (AI) and machine learning (ML) are increasingly influencing clinical research and development (R&D). Contract research organizations (CROs) and pharmaceutical companies can leverage these cutting-edge technologies to streamline clinical trials and introduce automation in drug discovery.

Clinical Trials 52

Clinical Trials Trials Clinical Research Treatment 52

H1 Blog

MAY 18, 2023

Clinical Research Organizations (CROs) play an important role in the success of clinical trials. CROs play an important role in facilitating successful clinical trials by providing crucial processes and resources necessary for achieving desired outcomes while reducing administrative burden on Principal Investigators.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

H1 Blog

DECEMBER 18, 2023

Pharmaceutical companies are on the brink of a tech revolution, and will embrace AI as a means to enhance their operations and research capabilities. In the near term, AI will be all about saving time, simplifying work processes, and knocking down language and jargon barriers in healthcare and clinical research.

Trials 64

Trials Clinical Trials FDA Pharmaceutical Companies 64

H1 Blog

NOVEMBER 29, 2023

By providing access to a more diverse range of patient populations, researchers can gather valuable data from underrepresented groups. In addition to improving inclusivity, data networks also have the potential to bridge the gap between developed and developing countries in terms of clinical research.

Clinical Trials 59

Clinical Trials Trials Drug Development Treatment 59